10x Genomics, Inc. Increase (Decrease) in Other Receivables
10x Genomics, Inc. (TXG) reported Increase (Decrease) in Other Receivables of -$32.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-08-07
- 10x Genomics, Inc. increase (decrease) in other receivables for the quarter ending 2026-06-30 was -$14.02M, a 120.47% decline year-over-year.
- 10x Genomics, Inc. increase (decrease) in other receivables for the quarter ending 2026-03-31 was -$18.13M.
- 10x Genomics, Inc. increase (decrease) in other receivables for the quarter ending 2025-12-31 was -$17.33M.
- 10x Genomics, Inc. increase (decrease) in other receivables for the quarter ending 2025-09-30 was -$16.28M.
- 10x Genomics, Inc. increase (decrease) in other receivables for fiscal 2025 was $34.87M.
- 10x Genomics, Inc. increase (decrease) in other receivables for fiscal 2024 was $0.00.
- 10x Genomics, Inc. increase (decrease) in other receivables for fiscal 2023 was $0.00.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$14.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$32.15M 10-Q · filed 2026-08-07 | -$49.48M derived: sum of 3 quarters · filed 2026-08-07 | -$65.76M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$18.13M 10-Q · filed 2026-05-08 | -$35.46M derived: sum of 2 quarters · filed 2026-05-08 | -$51.74M derived: sum of 3 quarters · filed 2026-05-08 | $16.75M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$17.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$33.61M derived: sum of 2 quarters · filed 2026-02-13 | $34.87M derived: sum of 3 quarters · filed 2026-08-07 | $34.87M 10-K · filed 2026-02-13 |
| 2025-09-30 | -$16.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $52.21M derived: sum of 2 quarters · filed 2026-08-07 | $52.21M 10-Q · filed 2025-11-07 | $52.21M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $68.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $68.48M 10-Q · filed 2026-08-07 | $68.48M derived: sum of 3 quarters · filed 2026-08-07 | $68.38M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | -$102.00K derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$102.00K derived: sum of 2 quarters · filed 2026-02-13 | $0.00 10-K · filed 2026-02-13 | |
| 2024-09-30 | -$102.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $102.00K 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-13 |